The Italian inflection point: Clinical strength, culture and capital

<p>In this episode of Denatured, you’ll hear from Diana Saraceni, founder and managing partner at Panakès Partners and Fabrizio Calisti, medical director at Angelini Ventures. We explore how Italy’s life sciences ecosystem has evolved over the last decade—from stronger tech transfer and growing venture capital to the gaps that still keep it from matching the UK, Germany or France in company creation and scale.</p><p></p><p><b>Host</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/jennifersmithparker/" target="_blank">Jennifer C. Smith-Parker</a>, Director of Insights, BioSpace</p><p></p><p><b>Guests</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/diana-saraceni-74994/" target="_blank">Diana Saraceni</a>, Founder and Managing Partner, Panakès Partners</p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/fabrizio-calisti-26109263/" target="_blank">Fabrizio Calisti</a>, Medical Director, Angelini Ventures</p><p></p><p><i>Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.</i></p>